2,883,371 Shares in LifeStance Health Group, Inc. $LFST Bought by Wellington Management Group LLP

by · The Markets Daily

Wellington Management Group LLP acquired a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) in the 2nd quarter, Holdings Channel.com reports. The firm acquired 2,883,371 shares of the company’s stock, valued at approximately $30,881,000.

Other large investors have also recently bought and sold shares of the company. BlackRock Inc. bought a new position in LifeStance Health Group in the 2nd quarter valued at about $389,293,000. Vanguard Group Inc. boosted its position in shares of LifeStance Health Group by 21.1% during the 4th quarter. Vanguard Group Inc. now owns 17,700,041 shares of the company’s stock worth $124,608,000 after acquiring an additional 3,086,506 shares in the last quarter. Silversmith Partners I GP LLC bought a new position in LifeStance Health Group in the fourth quarter valued at approximately $100,842,000. Dimensional Fund Advisors LP increased its stake in LifeStance Health Group by 16.4% in the first quarter. Dimensional Fund Advisors LP now owns 10,367,680 shares of the company’s stock valued at $66,038,000 after acquiring an additional 1,461,215 shares during the last quarter. Finally, Jennison Associates LLC raised its position in LifeStance Health Group by 38.5% during the first quarter. Jennison Associates LLC now owns 10,228,801 shares of the company’s stock valued at $65,157,000 after purchasing an additional 2,843,388 shares in the last quarter. 85.50% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have weighed in on LFST. Zacks Research cut LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. raised their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday, August 14th. The Goldman Sachs Group initiated coverage on LifeStance Health Group in a research report on Friday, June 5th. They issued a “neutral” rating and a $9.00 target price on the stock. Finally, BTIG Research increased their target price on shares of LifeStance Health Group from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $12.38.

Get Our Latest Analysis on LFST

Insider Transactions at LifeStance Health Group

In other news, COO Lisa Miller sold 47,912 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.85, for a total value of $519,845.20. Following the completion of the transaction, the chief operating officer owned 281,289 shares of the company’s stock, valued at $3,051,985.65. This represents a 14.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $10.62, for a total transaction of $144,890,858.34. Following the sale, the insider owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 14,671,917 shares of company stock worth $155,493,415. 3.50% of the stock is owned by corporate insiders.

LifeStance Health Group Stock Down 0.8%

Shares of LFST opened at $12.73 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. LifeStance Health Group, Inc. has a 52 week low of $4.77 and a 52 week high of $13.15. The stock has a market capitalization of $4.94 billion, a price-to-earnings ratio of 97.93 and a beta of 1.22. The stock has a fifty day moving average of $11.49 and a 200-day moving average of $8.80.

LifeStance Health Group (NASDAQ:LFSTGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business had revenue of $435.35 million for the quarter, compared to analyst estimates of $414.58 million. During the same quarter in the previous year, the company posted ($0.01) EPS. LifeStance Health Group’s quarterly revenue was up 26.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

LifeStance Health Group Company Profile

(Free Report)

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

Featured Articles

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report).